FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560334831> ?p ?o ?g. }

• W2560334831 endingPage "171" @default.
• W2560334831 startingPage "171" @default.
• W2560334831 abstract "171 Background: Oncotype DX Score is a 21-gene expression analysis that has been validated clinically as a reliable predictor of breast cancer recurrence for ER-positive, node-negative breast cancers. Obesity is recognized as a risk factor for many cancers, including breast cancer. Additionally obesity has been shown to be an independent prognostic factor in breast cancer. The primary objective of this study is to determine the correlation between obesity and Oncotype DX score, hence the relationship between obesity and breast cancer recurrence in ER-positive breast cancer. The secondary objective is to investigate the association between weight gain after diagnosis and breast cancer recurrence. Methods: An IRB-exempted retrospective chart review of female patients at Wellspan Group with ER-positive breast cancer who had Oncotype DX analysis in 2008 and 2009. Data collected included Oncotype DX score and BMI (at diagnosis, 6 months and 12 months). Data were analyzed to determine the correlation between Oncotype DX score and BMI at diagnosis, at 6 months and at 12 months. The correlation between Oncotype DX score and BMI changes at 12 months also was determined. Results: A total of 125 patients were identified; 103 had BMI recorded at diagnosis, 88 had BMI recorded at 6 months and 87 had BMI recorded at 12 months. Of these, we were able to determine the BMI changes at 12 months for 82 patients. The Pearson correlation scores were 0.091 (p = 0.361), 0.074 (p = 0.492), and 0.047 (p = 0.669) for BMI at diagnosis, at 6 months and at 12 months respectively. The Pearson correlation score was 0.007 (p = 0.948) for BMI changes at 12 months. Conclusions: Obesity and weight gain are not independent predictors of recurrence in patients with ER-positive breast cancer. The reported adverse prognostic associations may be more prominent in ER-negative breast cancers. This is consistent with the reports suggesting a higher rate of ER-negative, high-grade cancers in obese women as well as a greater magnitude of benefit from dietary and weight reduction interventions seen in women with ER-negative cancers." @default.
• W2560334831 created "2016-12-16" @default.
• W2560334831 creator A5019728839 @default.
• W2560334831 creator A5081571349 @default.
• W2560334831 date "2011-09-20" @default.
• W2560334831 modified "2023-10-18" @default.
• W2560334831 title "Is obesity associated with increased recurrence risk in estrogen receptor (ER)-positive breast cancer?" @default.
• W2560334831 doi "https://doi.org/10.1200/jco.2011.29.27_suppl.171" @default.
• W2560334831 hasPublicationYear "2011" @default.
• W2560334831 type Work @default.
• W2560334831 sameAs 2560334831 @default.
• W2560334831 citedByCount "1" @default.
• W2560334831 countsByYear W25603348312020 @default.
• W2560334831 crossrefType "journal-article" @default.
• W2560334831 hasAuthorship W2560334831A5019728839 @default.
• W2560334831 hasAuthorship W2560334831A5081571349 @default.
• W2560334831 hasConcept C117220453 @default.
• W2560334831 hasConcept C121608353 @default.
• W2560334831 hasConcept C126322002 @default.
• W2560334831 hasConcept C143998085 @default.
• W2560334831 hasConcept C2524010 @default.
• W2560334831 hasConcept C2780221984 @default.
• W2560334831 hasConcept C29456083 @default.
• W2560334831 hasConcept C33923547 @default.
• W2560334831 hasConcept C50440223 @default.
• W2560334831 hasConcept C511355011 @default.
• W2560334831 hasConcept C530470458 @default.
• W2560334831 hasConcept C71924100 @default.
• W2560334831 hasConcept C84606932 @default.
• W2560334831 hasConceptScore W2560334831C117220453 @default.
• W2560334831 hasConceptScore W2560334831C121608353 @default.
• W2560334831 hasConceptScore W2560334831C126322002 @default.
• W2560334831 hasConceptScore W2560334831C143998085 @default.
• W2560334831 hasConceptScore W2560334831C2524010 @default.
• W2560334831 hasConceptScore W2560334831C2780221984 @default.
• W2560334831 hasConceptScore W2560334831C29456083 @default.
• W2560334831 hasConceptScore W2560334831C33923547 @default.
• W2560334831 hasConceptScore W2560334831C50440223 @default.
• W2560334831 hasConceptScore W2560334831C511355011 @default.
• W2560334831 hasConceptScore W2560334831C530470458 @default.
• W2560334831 hasConceptScore W2560334831C71924100 @default.
• W2560334831 hasConceptScore W2560334831C84606932 @default.
• W2560334831 hasIssue "27_suppl" @default.
• W2560334831 hasLocation W25603348311 @default.
• W2560334831 hasOpenAccess W2560334831 @default.
• W2560334831 hasPrimaryLocation W25603348311 @default.
• W2560334831 hasRelatedWork W2136321264 @default.
• W2560334831 hasRelatedWork W2348152691 @default.
• W2560334831 hasRelatedWork W2369039771 @default.
• W2560334831 hasRelatedWork W2548165902 @default.
• W2560334831 hasRelatedWork W317834158 @default.
• W2560334831 hasRelatedWork W3205023169 @default.
• W2560334831 hasRelatedWork W377899687 @default.
• W2560334831 hasRelatedWork W4293147692 @default.
• W2560334831 hasRelatedWork W4323348991 @default.
• W2560334831 hasRelatedWork W2555822460 @default.
• W2560334831 hasVolume "29" @default.
• W2560334831 isParatext "false" @default.
• W2560334831 isRetracted "false" @default.
• W2560334831 magId "2560334831" @default.
• W2560334831 workType "article" @default.